The latest articles from BioStock
» BioStock Studio: CLS on Q4 and the news flow
» Iconovo aims for new customer agreements in 2022
» AlphaHelix predicts continued growth
» Carbiotix CEO expects to reach milestones in 2022
» New CEO and continued patient recruitment for WntResearch
Read BioStock's newsletter for v.7 here.
Lipum reports that the GMP manufacturing of SOL-116 has been successful and that the formulation is now ready for aseptic filling for use in clinical studies. Read more.
announces the recruitment of Fredrik Frick to the position of Head of Clinical Operations. Read more.
Orexos leading product ZUBSOLV is now on the Medicaid list of subsidized drugs in New York State. Read more.
Xspray Pharma provides an update on the latest developments for the company's first product Dasynoc. Read more.
Statement from SUFFER about the convertible loan agreement. Read more.
Christer Norstrom has been appointed acting chairman of the board of Realheart, where he has been a regular member since 2021. Read more.
Rehman Adil joins Cardo Health as co-founder and CTO. Read more.
Idogen presents at Erik Penser Bank's Health Care Theme Day on February 24th. Read more.
Polymer Factory announces that the redemption period for series TO1 begins today. Read more.
Pharmivas The CEO is interviewed in connection with the fourth quarter report. Read more.
Modus Therapeutics presents at Erik Penser Bank's Theme Day - Health Care. Read more.
Reports:
AcouBlack AcuCort ADDvise Group Alzinova Asarina Pharma Calliditas Therapeutics Cantargia Cessatech CLS Curasight Devyser Diagnostics Elekta Elos Medtech ExpreS2ion Biotechnologies Isofol Medical SUFFER Lipigon PExA Prostatype Genomics Realheart Saniona SelectImmune Pharma Stenocare
Invitations to report presentations:
News received since yesterday lunch:
Realheart and Berlin Heart have been granted a total of approximately SEK 10 million in grants from the EU program "Eurostar 3" for a joint project that will develop an automated manufacturing process for the manufacture of membranes. Read more.
BICO announced that a settlement had been reached with Organically regarding the disputes regarding Organovo's patents in which the companies have been involved. Read more.
Senzime has submitted an application to the US Food and Drug Administration FDA for approval of the company's new disposable sensor for children. Read more.
Peptonic Medical provided information about a detailed timetable for the decided rights issue of shares and warrants. Read more.
Maria Edlund has been recruited to the position of Drug Product Manufacturing Specialist at Scandinavian Biopharma. Read more.
Marking published correction due to mislabeling of 2021 year-end report. Read more.
Idogen announced the last day for trading in BTU and the first day for trading in warrants series TO 5. Read more.
Orphazyme updated regarding Arimoclomol. Read more.
Prostatype Genomics announced outcome in option exercise. Read more.
CombiGene published newsletters. Read more.
This morning's winner: Wnt 5,15% QuiaPEG 5% AdderaCare 3,33% Lipum 1,59%, BICO Group 1,27%
Morning loser: Prostatype Genomics -18,85% ObsteCare -18,05% Aino Health -16,67% ExpreS2ion Biotech -15,89% Fluicell -15,3%
Index: OMXS30 2056 -3,93%, Healthcare -3,34%